Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1 - PubMed (original) (raw)

doi: 10.1189/jlb.0604337. Epub 2004 Sep 30.

Affiliations

PMID: 15459235
DOI: 10.1189/jlb.0604337

Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1

Ramsey H McIntire et al. J Leukoc Biol. 2004 Dec.

Abstract

Throughout human pregnancy, activated maternal macrophages producing anti-inflammatory cytokines comprise a stable cell population in the uterus. This organ is also massively infiltrated with semiallogeneic, placenta-derived, invasive cytotrophoblast cells, which produce membrane and soluble isoforms of human leukocyte antigen (HLA)-G. Here, we investigated the possibility that two soluble isoforms of HLA-G, HLA-G5 and -G6, program macrophage production of cytokines. The model system consisted of human U937 myelomonocytic cells treated with phorbol 12-myristate 13-acetate (PMA) and interferon-gamma (IFN-gamma), which induced differentiation and activation but did not affect their viability or decrease their expression of the two inhibitory immunoglobulin-like transcript (ILT) receptors for HLA-G, ILT2 and ILT4. Exposure of the PMA/IFN-gamma-treated U937 cells to increasing concentrations of recombinant HLA-G5 or -G6 (rG5 and rG6) stimulated effects common to the two isoforms. High doses of both significantly decreased interleukin (IL)-10 and dramatically increased transforming growth factor-beta1. Differential effectiveness between the isoforms was demonstrated in dose-response studies, as was differential binding to ILT2 and ILT4 in receptor-blocking studies. No effects on production of IL-4, IL-1 receptor antagonist, IL-15, tumor necrosis factor alpha, IL-1beta, or IL-6 were observed. Collectively, the results are consistent with the postulate that environmental programming of decidual macrophages may be dictated in part by their proximity to soluble HLA-G-producing fetal cytotrophoblast cells.

PubMed Disclaimer

Cited by

HLA-G and its role in implantation (review).
Roussev RG, Coulam CB. Roussev RG, et al. J Assist Reprod Genet. 2007 Jul;24(7):288-95. doi: 10.1007/s10815-007-9148-3. Epub 2007 Jul 14. J Assist Reprod Genet. 2007. PMID: 17629722 Free PMC article. Review.
Stranger in a strange land.
Hunt JS. Hunt JS. Immunol Rev. 2006 Oct;213:36-47. doi: 10.1111/j.1600-065X.2006.00436.x. Immunol Rev. 2006. PMID: 16972895 Free PMC article. Review.
The HLA-G genotype is associated with IL-10 levels in activated PBMCs.
Rizzo R, Hviid TV, Stignani M, Balboni A, Grappa MT, Melchiorri L, Baricordi OR. Rizzo R, et al. Immunogenetics. 2005 May;57(3-4):172-81. doi: 10.1007/s00251-005-0788-0. Epub 2005 Apr 2. Immunogenetics. 2005. PMID: 15900488
A commentary on gestational programming and functions of HLA-G in pregnancy.
Hunt JS, Morales PJ, Pace JL, Fazleabas AT, Langat DK. Hunt JS, et al. Placenta. 2007 Apr;28 Suppl A(Suppl A):S57-63. doi: 10.1016/j.placenta.2007.01.004. Epub 2007 Mar 9. Placenta. 2007. PMID: 17350091 Free PMC article.
Maternal Obesity and the Uterine Immune Cell Landscape: The Shaping Role of Inflammation.
St-Germain LE, Castellana B, Baltayeva J, Beristain AG. St-Germain LE, et al. Int J Mol Sci. 2020 May 27;21(11):3776. doi: 10.3390/ijms21113776. Int J Mol Sci. 2020. PMID: 32471078 Free PMC article. Review.

Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1 - PubMed (original) (raw)